Page last updated: 2024-08-23

dobutamine and mci 154

dobutamine has been researched along with mci 154 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, Y; Kitada, Y; Narimatsu, A2
Abe, Y; Kitada, Y; Narimatsu, A; Tobe, A1
Ohizumi, Y1
Mori, M; Takaoka, H; Takeuchi, M; Yokoyama, M1
Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamaguchi, K; Yamakawa, H; Yokoyama, M1
Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamakawa, H; Yokoyama, M1

Reviews

1 review(s) available for dobutamine and mci 154

ArticleYear
[Tendency of development on novel type of cardiotonic drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 1993, Volume: 51, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Amrinone; Animals; Calcium; Catechols; Dobutamine; Dopamine; Fatty Alcohols; Heart Failure; Humans; Pyridazines; Troponin

1993

Trials

1 trial(s) available for dobutamine and mci 154

ArticleYear
Lusitropic effects of a Ca2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts.
    Cardiovascular research, 1995, Volume: 30, Issue:6

    Topics: Adult; Aged; Angina Pectoris; Calcium; Cardiac Catheterization; Cardiotonic Agents; Coronary Disease; Diastole; Dobutamine; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Pyridazines; Stimulation, Chemical; Ventricular Function, Left

1995

Other Studies

5 other study(ies) available for dobutamine and mci 154

ArticleYear
Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:3

    Topics: Acidosis; Animals; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Milrinone; Myocardial Contraction; Pyridazines; Pyridones

1992
Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent.
    European journal of pharmacology, 1991, Jan-10, Volume: 192, Issue:2

    Topics: Adenosine Triphosphate; Animals; Calcium; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Male; Milrinone; Myocardial Contraction; Myocardium; Pyridazines; Pyridones; Ventricular Function, Left

1991
Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2

    Topics: Animals; Cardiotonic Agents; Coronary Circulation; Coronary Vessels; Dobutamine; Dogs; Female; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxygen Consumption; Pyridazines

1993
Beneficial effects of a Ca2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor.
    American heart journal, 1997, Volume: 133, Issue:3

    Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Humans; Imidazoles; Myocardial Infarction; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Ventricular Dysfunction, Left

1997
Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts.
    Journal of the American College of Cardiology, 1997, Mar-01, Volume: 29, Issue:3

    Topics: Aged; Cardiotonic Agents; Constriction, Pathologic; Coronary Disease; Dobutamine; Energy Metabolism; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pyridazines; Ventricular Function, Left; Ventricular Pressure

1997